avkАрхивъ внутренней медициныThe Russian Archives of Internal Medicine2226-67042411-6564“SINAPS” LLC10.20514/2226-6704-2016-6-6-5-11avk-592Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИСЕМЕЙНАЯ СРЕДИЗЕМНОМОРСКАЯ ЛИХОРАДКА: ОБЗОР РЕКОМЕНДАЦИЙ EULAR, 2016FAMILIAL MEDITERRANEAN FEVER: THE REVIEW OF EULAR GUIDELINES, 2016ВатутинН. Т.VatutinM. T.a.smyrnova@mail.ruСмирноваА. С.SmyrnovaG. S.a.smyrnova@mail.ruЭль-ХатибМ. А.El-KhatibA.a.smyrnova@mail.ruДонецкий национальный медицинский университет им. М. Горького, Донецк, Украина Институт неотложной и восстановительной хирургии им. В. К. Гусака, Донецк, УкраинаУкраинаM. Gorky Donetsk National Medical University, Donetsk , Ukraine V. K. Gusak Institute of Emergency and Reconstructive Surgery, Donetsk, UkraineUkraineЦентр первичной медико-санитарной помощи № 5, Макеевка, УкраинаУкраинаCenter for Primary Health Care № 5, Makeevka, UkraineUkraine20163012201666511Copyright © Ватутин Н.Т., Смирнова А.С., Эль-Хатиб М.А., 20162016Ватутин Н.Т., Смирнова А.С., Эль-Хатиб М.А.Vatutin M.T., Smyrnova G.S., El-Khatib A.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.medarhive.ru/jour/article/view/592

В сообщении представлены основные положения клинических рекомендаций по лечению семейной средиземноморской лихорадки Европейской антиревматической лиги (EULAR, 2016).

Recommendations for the management of familial Mediterranean fever are reflected in presented translation of new international guidelines (EULAR, 2016)

семейная средиземноморская лихорадкалечениерекомендацииfamilial Mediterranean fevertreatmentguidelinesReferencesOzen S., Demirkaya E., Erer B. et al. EULAR recommendations for the management of familial Mediterranean fever. Ann. Rheum. Dis. 2016; 75: 644–651.Ozen S., Demirkaya E., Erer B. et al. EULAR recommendations for the management of familial Mediterranean fever. Ann. Rheum. Dis. 2016; 75: 644–651.Федоров Е.С., Салугина С.О., Кузьмина Е.Е. Семейная средиземноморская лихорадка (периодическая болезнь): современный взгляд на проблему. Современная ревматология. 2013; 1: 24-29.Федоров Е.С., Салугина С.О., Кузьмина Е.Е. Семейная средиземноморская лихорадка (периодическая болезнь): современный взгляд на проблему. Современная ревматология. 2013; 1: 24-29.Fedorov E.S., Salugina S.O., Kuzmina N.N. Familial Mediterranean fever (a periodic disease): The present-day view of the problem. Modern Rheumatology Journal. 2013; 7(1): 24-30 [In Russian].Fedorov E.S., Salugina S.O., Kuzmina N.N. Familial Mediterranean fever (a periodic disease): The present-day view of the problem. Modern Rheumatology Journal. 2013; 7(1): 24-30 [In Russian].Livneh A., Langevitz P., Zemer D. et al. Criteria for the diagnosis of familial Mediterranean fever. Arthr. Rheum. 1997; 40: 1879–1885.Livneh A., Langevitz P., Zemer D. et al. Criteria for the diagnosis of familial Mediterranean fever. Arthr. Rheum. 1997; 40: 1879–1885.Cerquaglia C., Diaco M., Nucera G. et al. Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update. Curr. Drug Targets Inflamm. Allergy. 2005; 4(1): 117-124.Cerquaglia C., Diaco M., Nucera G. et al. Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update. Curr. Drug Targets Inflamm. Allergy. 2005; 4(1): 117-124.Vitale A., Rigante D., Lucherini O.M. et al. Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm. 2013; 2: 939847.Vitale A., Rigante D., Lucherini O.M. et al. Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm. 2013; 2: 939847.Sozeri B., Kasapcopur O. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis. Curr. Med. Chem. 2015; 22(16): 1986-1991.Sozeri B., Kasapcopur O. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis. Curr. Med. Chem. 2015; 22(16): 1986-1991.Soriano A., Verecchia E., Afeltra A. et al. IL-1β biological treatment of familial Mediterranean fever. Clin. Rev. Allergy Immunol. 2013; 45(1): 117-130.Soriano A., Verecchia E., Afeltra A. et al. IL-1β biological treatment of familial Mediterranean fever. Clin. Rev. Allergy Immunol. 2013; 45(1): 117-130.

The authors declare that there are no conflicts of interest present.